0 items USD 0.00Search
Your search for "hjresearch global benign prostatic hyperplasia bph treatment industry market research 2019" gave back 1549442 results.
Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense...
Catalog:
MRRPB5
January 2023
Price: USD 4,000.00
The global BPH Treatment Equipment market size is expected to reach $ 3445 million by 2029, rising at a market growth of 5.1% CAGR during the...
Catalog:
GIR
May 2023
Price: USD 4,480.00
Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
BPH (Benign Prostatic Hyperplasia) is a medical condition in which the prostate gland becomes enlarged, causing urinary problems. There are several...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
The global BPH Treatment Equipment market size was valued at USD 2436.6 million in 2022 and is forecast to a readjusted size of USD 3445 million by...
Catalog:
GIR
May 2023
Price: USD 3,480.00
The “PVA Foam Embolization Particles Industry Forecast” looks at past sales and reviews total world PVA Foam Embolization Particles sales in 2022,...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Finasteride Oral Tablet is a medication used for the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness (MPB). The global...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Summary The Benign Prostate Hyperplasia Drugs market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx...
Catalog:
HYR
March 2021
Price: USD 2,000.00
Finasteride, sold under the brand names Proscar and Propecia among others, is a medication used for the treatment of benign prostatic hyperplasia (...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Finasteride, sold under the brand names Proscar and Propecia among others, is a medication used for the treatment of benign prostatic hyperplasia (...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The goal of Benign prostate hyperplasia drugs is to reduce morbidity and prevent complications.Agents used include alpha-adrenergic blockers, 5-alpha...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Highlights The global PVA Foam Embolization Particles market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
According to our Publisher latest study, the global PVA Foam Embolization Particles market size was valued at USD million in 2022 and is forecast to...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Finasteride, sold under the brand names Proscar and Propecia among others, is a medication used for the treatment of benign prostatic hyperplasia (...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Prostate Smooth Muscle Cells (PrSMC) market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
